Crossref
Precision in practice: a new standard in early-relapsing HR+ breast cancer
AME Clinical Trials Review · 2026-06 · 4 · 27-27
DOI: 10.21037/actr-25-112 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-06. Verfasst von Nathalie LeVasseur und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
LeVasseur, N., & Gelmon, K. A. (2026). Precision in practice: a new standard in early-relapsing HR+ breast cancer. AME Clinical Trials Review, 4, 27-27. https://doi.org/10.21037/actr-25-112
Vancouver
LeVasseur N, Gelmon KA. Precision in practice: a new standard in early-relapsing HR+ breast cancer. AME Clinical Trials Review. 2026;4:27-27. doi:10.21037/actr-25-112
BibTeX
@article{LeVasseur2026,
author = {LeVasseur, Nathalie and Gelmon, Karen A.},
title = {Precision in practice: a new standard in early-relapsing HR+ breast cancer},
journal = {AME Clinical Trials Review},
year = {2026},
volume = {4},
pages = {27--27},
doi = {10.21037/actr-25-112}
}
EUVIMED